Skip to content

Clinical trials

Phase 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Phase: Phase 1 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20201
20211
20221
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tongji Hospital3
Centre Hospitalier Universitaire de Nīmes1
Kine Sciences Co., Ltd.1
Kite, A Gilead Company1
Pfizer1
Rutgers, The State University of New Jersey1
TG Therapeutics, Inc.1
Tianjin Huanhu Hospital1
Xuanwu Hospital, Beijing1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating11
Multiple Sclerosis7
Myasthenia Gravis7
Neuromyelitis Optica5
Autoimmune Diseases of the Nervous System4
Myositis2
Agammaglobulinemia1
Autoimmune Diseases1
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease1
Obesity1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.